论文部分内容阅读
目的研究盐酸氨溴索不同给药方式治疗小儿肺炎的临床疗效。方法随机抽取2011年1月至2011年12月住院并确诊为小儿肺炎的患者80例,分为治疗组和对照组两组,治疗组采用盐酸氨溴索雾化吸入40例,对照组采用盐酸氨溴索入液静脉滴注40例,两组的一般治疗相同。结果治疗组的总有效率(92.5%)明显高于对照组总有效率(77.5%),差异有统计学意义(P<0.05)。结论盐酸氨溴索雾化吸入疗效确切、不良反应小、痛苦小、安全性高,将逐渐代替静脉应用,并将广泛用于临床治疗各种呼吸性疾病。
Objective To study the clinical efficacy of different administrations of ambroxol hydrochloride in children with pneumonia. Methods A total of 80 hospitalized patients diagnosed as pediatric pneumonia from January 2011 to December 2011 were randomly divided into treatment group and control group. In the treatment group, 40 cases were inhaled with ambroxol hydrochloride and the control group was treated with hydrochloric acid Ambroxol infusions intravenous infusion of 40 cases, the two groups of the same general treatment. Results The total effective rate (92.5%) in the treatment group was significantly higher than that in the control group (77.5%), the difference was statistically significant (P <0.05). Conclusion Ambroxol Hydrochloride inhalation has definite curative effect, little adverse reaction, little pain and high safety. It will gradually replace intravenous application and will be widely used in the clinical treatment of various respiratory diseases.